Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2015 / Articles / May / Real-time particle sizing for granulation control
Business & Regulation Business Practice Trends & Forecasts

Real-time particle sizing for granulation control

05/07/2015 1 min read

Share

Benefit of laser diffraction and spatial filter technique for dry and wet granulation
Across the pharmaceutical, food and chemical industries, granulation processes are used to convert light, fine powders into larger, more dense granules, to make fast-dissolving drinks, optimized blends for compression tableting and granules for waste water absorption applications, for example. Also in the manufacture of catalysts. Whether granulation is dry or wet the goal is to produce granules that fulfill the requirements of subsequent processing steps or end use. Particle size is often a defining characteristic. This paper considers various granulation processes and the use of real-time particle size measurement in their optimization, focusing on two different sizing methods: laser diffraction and the spatial filter technique (SFT). Case studies illustrate the potential benefits associated with continuous particle size measurement.

Why include a granulation step?
Handling fine powders can be problematic, with materials in the sub-10 micron range being especially challenging. The strong forces of attraction between fine particles lead to high cohesivity and poor flowability, compromising efficient manufacture and use. From the point of view of safety such materials can also present a significant dust hazard. The granulation of fine powders, alone or in a blend, tackles these issues, potentially eliminating any dust hazard, improving flowability and enabling the close control of:
  • Wettability
  • Bulk density
  • Product appearance
  • Compressibility
  • Abrasiveness
  • Solubility
  • Drying properties
  • Absorptive capacity
Granulation of a blend can also help to prevent segregation thereby ensuring product uniformity. The production of tablets within the pharmaceutical industry is a primary application that exemplifies the use of granulation. In tablet formulations the active ingredient, as well as being fine and cohesive, may be present only in extremely low concentrations. Physical dissimilarity between active and other constituents of the tablet is also a common problem, one that tends to promote segregation. Successful tablet production at the rates achievable with modern presses calls for a highly fluid blend that compresses rapidly to form a stable tablet. Granulating the active, alone or in combination with the excipients, is one way to produce a uniform feed that meets this specification, from an otherwise difficult formulation. Click here to read the full article

Company profile  Malvern Panalytical technologies are used by scientists and engineers in a wide range of industries and organizations to solve the challenges associated with maximizing productivity, developing better quality products and getting them to market faster. Our mission is to create superior, customer-focused solutions and services to deliver tangible economic impact through chemical, physical and structural analysis of materials.

Underpinned by extensive industry knowledge and technical and applications expertise, Malvern Panalytical instruments help users better understand a wide variety of materials, from proteins and polymers to metals and building materials. Our technologies enable the measurement of parameters such as particle size, shape and zeta potential, biomolecular interactions and stability, rheological properties, elemental concentrations and crystallographic structure. Highly reliable and robust characterization of these properties is fundamental to predicting how a product will behave during use, to optimizing its performance and achieving manufacturing excellence. Markets Served Malvern Panalytical products and solutions for Discovery, Research & Development, Process Control, and Product Quality Assurance are sold primarily into four market sectors: Pharma/Food/Bio, Metals/Mining/Minerals, Chemicals/ Petrochemicals, and Advanced Materials sector which includes many academic and government research facilities around the world. Company Background Malvern Panalytical was formed by the merger of the businesses Malvern Instruments (Malvern, UK) and PANalytical, including ASD and Claisse (Almelo, the Netherlands) on 1st January 2017, and employs over 2,000 people worldwide. With R&D and manufacturing sites in North America, Europe and China, and a global sales and service presence, Malvern Panalytical provides unrivalled levels of customer support. Malvern Panalytical is a leader in the materials characterization market, developing expert analytical solutions which deliver superior actionable insight. www.malvern.com severine.michel@malvern.com

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

What Trump’s Latest Moves Mean for the Industry
Business Practice Standards & Regulation Trends & Forecasts Bioprocessing - Upstream & Downstream
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
Business Practice Trends & Forecasts
Big Bad Pharma?

December 1, 2014

0 min read

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
Business Practice Trends & Forecasts
Access All Areas

December 1, 2014

0 min read

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
Business Practice Trends & Forecasts
Care to ‘Patent Dance’?

December 1, 2014

0 min read

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.